Location: | Chelsea |
---|---|
Salary: | £55,329 (Circa) per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 19th May 2025 |
---|---|
Closes: | 6th June 2025 |
Key Information
Salary: circa £55,329.00Job Details
Under the guidance of Professor Nick James, we are seeking to recruit a Clinical Research Fellow in Urological Cancer to contribute to the STAMPEDE trial Arm P as maternity leave cover.
The maternity leave cover post will provide experience and training for a candidate wishing to try clinical research or embarking on training in oncology, or for more senior oncology trainees seeking post-training research exposure. The role of the post-holder will primarily be ensuring the smooth clinical operation of the research project and will also provide experience in the relevant analytical techniques.
The post would suit a trainee wishing to enter oncology and will include attendance at one oncology clinic per week. Clinical supervision will be tailored to the prior experience of the successful candidate.
About you
The successful candidate must have:
Department/Directorate Information
The Prostate and Bladder Cancer Research Team seek to improve patient outcomes by improving and designing large scale clinical trials for prostate and bladder cancer.
The Division of Radiotherapy and Imaging brings together research groups that work on how to use radiation therapy, guided by state-of-the-art imaging techniques, in the most effective way to cure cancer. Our work is based on the central idea that the best outcomes will be achieved by delivering curative radiation doses to tumours, while limiting radiation damage of neighbouring normal tissues. Our therapy often includes adding drug treatments alongside radiation therapy as a means of killing cancer cells more effectively and, at the same time, activating anti-tumour immune responses. Preclinical work includes research that combines radiation therapy with radiation sensitisers and biological response modifiers (oncolytic viruses, innate immune activators, immune checkpoint inhibitors) to maximise anti-tumour efficacy and give protection against tumour recurrence. Multiple translational clinical studies seek to address these themes through our collaborators in the Royal Marsden. Overall, our mission is to cure more patients with fewer immediate and long-term side effects of treatment.
What we offer
We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Professor Nick James via email on nick.james@icr.ac.uk
Type / Role:
Subject Area(s):
Location(s):